GlaxoSmithKline receives boost in China

A two-dose course of its cervarix jab was approved for use on Chinese girls aged between nine and 14 in a bid to prevent cervical cancer.

GlaxoSmithKline receives boost in China
A two-dose course of its cervarix jab was approved for use on Chinese girls aged between nine and 14 in a bid to prevent cervical cancer.